Evaluation suboptimal outcomes in Crohn's disease patients with biologic treatment

被引：0
|
作者：
Chen, Nai-Yu [1 ]
Chuang, Chiao-Hsiung [2 ]
Chang, Yu-Ching [3 ]
Cheng, Ching-Lan [1 ]
机构：
[1] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Sch Pharm, Coll Med, Tainan, Taiwan
[2] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Internal Med, Coll Med, Tainan, Taiwan
[3] Natl Cheng Kung Univ, Hlth Outcome Res Ctr, Tainan, Taiwan
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
625
引用
收藏
页码：292 / 293
页数：2
相关论文
共 50 条
  • [1] SUBOPTIMAL TREATMENT IN PATIENTS WITH CROHN'S DISEASE USING BIOLOGICS
    Gagnon-Sanschagrin, Patrick
    Sanon, Myrlene
    Davidson, Mikhail
    Willey, Cynthia
    Kachroo, Sumesh
    Hoops, Timothy
    Naessens, Dominik
    Guerin, Annie
    Cloutier, Martin
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S541 - S542
  • [2] Indicators of Suboptimal Treatment and Associated Healthcare Costs Among Patients With Crohn's Disease Initiated on Biologic or Conventional Agents
    Pilon, Dominic
    Ding, Zhijie
    Muser, Erik
    Manceur, Ameur M.
    Vermette-Laforme, Maude
    Lafeuille, Marie-Helene
    Lefebvre, Patrick
    [J]. CROHNS & COLITIS 360, 2022, 4 (03)
  • [3] Indicators of Suboptimal Biologic Therapy in Patients With Ulcerative Colitis or Crohn's Disease in the United States
    Mody, Reema
    Patel, Haridarshan
    Rubin, David T.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S824 - S824
  • [4] Crohn's Disease of the Esophagus: Clinical Features and Treatment Outcomes in the Biologic Era
    De Felice, Kara M.
    Katzka, David A.
    Raffals, Laura E.
    [J]. INFLAMMATORY BOWEL DISEASES, 2015, 21 (09) : 2106 - 2113
  • [5] THE OCCURRENCE OF SUBOPTIMAL BIOLOGIC TREATMENT IN PATEINTS WITH CROHN'S DISEASE: A SWEDISH NATIONWIDE POPULATION-BASED STUDY
    Cai, Qian
    Borsum, Jakob
    Isheden, Gabriel
    Hjelm, Fredrik
    Wirth, Daniel
    Sanon, Myrlene
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S542 - S543
  • [6] Indicators of suboptimal biologic therapy over time in patients with ulcerative colitis and Crohn's disease in the United States
    Patel, Haridarshan
    Lissoos, Trevor
    Rubin, David T.
    [J]. PLOS ONE, 2017, 12 (04):
  • [7] Positioning Biologic Agents in the Treatment of Crohn's Disease
    Hanauer, Stephen B.
    [J]. INFLAMMATORY BOWEL DISEASES, 2009, 15 (10) : 1570 - 1582
  • [8] Effects of Preoperative Use of Biologic Agents on Operative Outcomes in Crohn's Disease Patients
    Kamel, Amir Y.
    Ayoub, Fares
    Banerjee, Debdeep
    Chaudhry, Naueen
    Ader, Yan
    Tan, Sanda
    Zimmermann, Ellen M.
    Glover, Sarah C.
    Iqbal, Atif
    [J]. AMERICAN SURGEON, 2018, 84 (09) : 1526 - 1530
  • [9] Comparative Evaluation of Treatment Outcomes in Patients With Crohn's Disease Treated With Ustekinumab vs Vedolizumab
    Chiorean, Michael V.
    Jiang, Jeanne
    Candela, Ninfa M.
    Chen, Grace
    Romdhani, Hela
    Latremouille-Viau, Dominick
    Shi, Sherry
    Bungay, Rebecca
    Fan, Tao
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S392 - S392
  • [10] FACTORS ASSOCIATED WITH BIOLOGIC TREATMENT DE-ESCALATION IN PATIENTS WITH CROHN'S DISEASE
    Lien, P. W.
    Lee, T. A.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S38 - S38
12345